Toripristone

This classification denotes an anti-progestin, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 711D76P884. European Medicines Agency schedules Toripristone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11198MIG. Toripristone generally arises in the molecular formula C31H39NO2. The term TORIPRISTONE is an International Non-Proprietary Name or INN. TORIPRISTONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule toripristone under HS 29372900 and SITC 54153. As of Q4 2014, TORIPRISTONE remains the US FDA Preferred Term for this commodity. Toripristone bears US NLM identifiers UMLS ID C2984007 and NCI Concept Code C91055. SMILES: OC1(C2(C(C3C(=C4C(=CC(=O)CC4)CC3)C(C2)c2ccc(N(C(C)C)C)cc2)CC1)C)C#CC.